Ricalde, Alvin M.
HRN: 22-20-92 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/10/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
10/10/2025
10/16/2025
IV
2.25g
Q6
Sepsis Sec To Complicated Uti
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes